Alexion Pharmaceuticals, Inc.
LIQUID FORMULATIONS OF ANTI-CD200 ANTIBODIES

Abstract:

The present disclosure provides stable liquid pharmaceutical formulations comprising anti-CD200 antibodies or antigen-binding fragments thereof, and articles of manufacture and kits containing the formulations. Also featured are methods of using the formulations in cancer and autoimmune therapies, and for preventing, delaying or treating cell, tissue, or organ transplant rejection.